EquityZen Growth Technology Fund LLC - Series 240
Raised
$1M
Investors
3
Min Invest
$249,965
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 240 is a Delaware LLC filed by EquityZen Advisors on 2018-12-19, raising $1.2M from 3 investors under Rule 506(b) and Section 3(c)(1). The offering carries a $250K minimum investment and is part of the EquityZen platform, which operates 1,891 related entities focused on pre-IPO secondary market access through individual series vehicles.
This pre-IPO pooled investment fund uses the standard 506(b)/3(c)(1) exemption pattern typical of private fund structures targeting accredited investors. The $250K minimum is moderate for the pre-IPO secondary category, consistent with retail-accessible institutional minimums, and the $400K average check size across 3 investors suggests a small early-stage close or single-company exposure vehicle.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Shriram Bhashyam
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
